Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIV-Reference-Cited by-同舟云学术

Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIV

Published:2018-08-15 Issue:1 Volume:78 Page:S40-S48
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Ford Deborah,Turner Rebecca,Turkova Anna,Penazzato Martina,Musiime Victor,Bwakura-Dangarembizi Mutsa,Violari Avy,Chabala Chishala,Puthanakit Thanyawee,Sudjaritruk Tavitiya,Cressey Tim R.,Lallemant Marc,Gibb Diana M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference51 articles.

1. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis;Newell;Lancet.,2004

2. Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study;Picat;PLoS Med.,2013

3. Extrapolation of adult data and other data in pediatric drug-development programs;Dunne;Pediatrics.,2011

4. Developmental pharmacology–drug disposition, action, and therapy in infants and children;Kearns;N Engl J Med.,2003

5. Prioritizing the most needed formulations to accelerate paediatric antiretroviral therapy scale-up;Penazzato;Curr Opin HIV AIDS.,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing Research and Development of Anti-infectives for Children: A Clinical Development Perspective;International Journal of Antimicrobial Agents;2024-08

2. Towards molecular-pathology informed clinical trials in childhood arthritis to achieve precision medicine in juvenile idiopathic arthritis;Annals of the Rheumatic Diseases;2022-12-05

3. Combining factorial and multi-arm multi-stage platform designs to evaluate multiple interventions efficiently;Clinical Trials;2022-05-17

4. ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing;BMC Infectious Diseases;2021-01-04

5. Adult dolutegravir doses in children;The Lancet HIV;2020-08